Diagonal Therapeutics

About:

Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies.

Website: https://www.diagonaltx.com

Top Investors: RA Capital Management, Lightspeed Venture Partners, Frazier Life Sciences, Biotechnology Value Fund, Viking Global Investors

Description:

Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles associated with agonist antibody drug development.

Total Funding Amount:

$128M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)diagonaltx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-04-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai